Nigeria contributes significantly to the burden of measles, rubella and cVPV2 globally (in Africa, 54% for polio, second highest for measles after DRC)
• The campaign is being implemented to:
• Close immunity gaps
• MR vaccine has a better seroconversion than measles-only vaccine – >90% VS 85%
• Protect a large cohort (9 months -14 years) and bridge the gaps in those who have never received Rubella
• Starts the drive towards reducing the incidence of Congenital rubella syndrome (CRS)
• Interrupt transmission of Polio, Measles and Rubella infections
• Strengthen Routine Immunisation( including HPV in girls 9yrs old), second year of life (2YL) activities, and integration into broader PHC interventions for healthier communities
• Addressing vaccine inequities
• Strive towards elimination of Polio, measles and rubella
• Piloting Health Campaign Effectiveness for better campaigns in Nigeria
